OPEN END TURBO LONG - BAUSCH HEALTH Stock

Certificat

DE000MD7V0C7

Market Closed - Börse Stuttgart 11:27:56 2024-05-17 am EDT
1.06 EUR -14.52% Intraday chart for OPEN END TURBO LONG - BAUSCH HEALTH
Current month-62.28%
1 month-63.70%
Date Price Change
24-05-17 1.06 -14.52%
24-05-16 1.24 -0.80%
24-05-15 1.25 -8.09%
24-05-14 1.36 +7.09%
24-05-13 1.27 +15.45%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 11:27 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BAUSCH HEALTH COMPANIES INC.
Issuer Morgan Stanley
WKN MD7V0C
ISINDE000MD7V0C7
Date issued 2022-09-05
Strike 5.864 $
Maturity Unlimited
Parity 1 : 1
Emission price 1.57
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.71
Lowest since issue 0.73

Company Profile

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
Sector
-
More about the company

Ratings for Bausch Health Companies Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Bausch Health Companies Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
6.77 USD
Average target price
9.786 USD
Spread / Average Target
+44.55%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW